RareResearch.AI
← Back to atlas

W700S

Category 2 — Moderately DestabilizingLikely pathogenicLumenal · predictedσ-1 candidateEditorial
TryptophanSerine at position 700 · C-terminal lumenal domain (653-869) · WFS1 (Wolframin)

Tryptophan → Serine at position 700 in wolframin's C-terminal lumenal domain. ClinVar Likely pathogenic. AlphaMissense 0.996 (deeply pathogenic), DynaMut2 ΔΔG -2.49 kcal/mol (destabilising). Together with V779G, the second of only two Cat 2 variants in the entire 245-variant Atlas.

Interactive 3D Structure

Wild-type reference
Wild-type W700 — hydrogen bond to F825
Fullscreen ↗
DynaMut2 mutant · W700S
Mutant S700 — hydrogen bond to L664 lost (13 contacts lost)
Fullscreen ↗

Bond changes · DynaMut2 interaction analysis

13 lost1 gained3 preserved
Interaction typeWild-type partnerMutant partnerStatus
Hydrogen bondL664Lost
Hydrogen bondE824E824Preserved
Hydrogen bondF825F825Preserved
Polar contactL664Lost
Polar contactE824Lost
Polar contactF825F825Preserved
Aromatic / πW666Lost
Aromatic / πY669Lost
Van der WaalsF825Gained
HydrophobicW666Lost
HydrophobicY669Lost
HydrophobicV698Lost
HydrophobicM781Lost
HydrophobicI802Lost
HydrophobicF825Lost
HydrophobicL829Lost
HydrophobicF840Lost

Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.

Computational Predictions

DynaMut2 ΔΔG
-2.49kcal/mol
Destabilising — large
AlphaMissense
0.996
LPath
AlphaFold pLDDT
90
model confidence
Schema
Cat 2
Category 2 — Moderately Destabilizing
ΔΔG confidence: Standard confidence · Lumenal

This variant is in a water-facing region, which is the regime the stability predictor was built and benchmarked for. Ordinary predictor error still applies.

Clinical Evidence

ClinVar classificationLikely pathogenic
Review statuscriteria provided, single submitter
Associated conditions(no specific conditions catalogued for W700S — ClinVar Likely pathogenic classification established by review evidence)
InheritanceInheritance pattern not specified in this ClinVar entry. WFS1 supports both autosomal dominant (DFNA6/14/38, Wolfram-like syndrome) and autosomal recessive (classical Wolfram syndrome) presentations; the W700 position appears in both contexts depending on the substituting residue.
Population frequency (gnomAD v4)Absent from gnomAD v4
cDNA changec.2099G>C
ClinVar accessionVCV004802689
Last evaluated2025/02/27 00:00

Not observed in ~730k individuals — consistent with a rare allele (ACMG PM2_supporting).

Classified for1★ unverified submission

ClinVar classifies this variant as Likely pathogenic, but does not state what it is classified for. ClinVar records the condition only as "not provided". A classification without a phenotype and an inheritance mode cannot be read as a statement about Wolfram syndrome risk or severity.

  • Phenotype scope is interpretation of submitted records. The computed values on this card (AlphaMissense, DynaMut2 ΔΔG, pLDDT) are measurements of the model, not of a patient.
  • Presentation cannot be generalised from neighbouring variants: one nucleotide over can present very differently. Structural similarity supports a mechanistic hypothesis, never a phenotype claim.

Review status: 1★ single submitter. ClinVar "conditions" is the union of all submissions; 0–1★ entries are submitted conditions, not documented phenotypes.

Population frequency
Global (all ancestries)
Absent from gnomAD v4
Homozygotes
Not available

No population breakdown — the variant is absent from gnomAD v4, so no ancestry group has an observed frequency.

No homozygotes — the variant is absent from gnomAD v4 altogether.

Source: gnomAD r4, retrieved 2026-08-21. Values are allele frequencies. The carrier estimate is derived from the allele frequency (Hardy-Weinberg, ~2·AF) and is an approximation, not a published figure — where a published carrier frequency exists it outranks this column and is cited on the card.

Structural Context

Position 700 sits in wolframin's C-terminal lumenal domain (residues 653–869), the protein's largest soluble region and the documented site of partner interactions with ATF6 (the master regulator of the unfolded protein response) and the Na+/K+ ATPase β1 subunit. The AlphaFold model shows W700 packed against immediate sequence neighbors THR699 (2.5 Å) and THR701 (2.4 Å), and into a distant hydrophobic pocket containing PHE825 (3.9 Å) and MET781 (4.8 Å). The aromatic indole ring of tryptophan provides a substantial hydrophobic contact surface against PHE825 — likely a π-stacking or edge-face aromatic interaction — and into the lipid-like pocket lined by methionine.

Replacing tryptophan with serine at this position removes the indole ring entirely and replaces it with a small polar hydroxyl. The volume loss is approximately 130 ų — among the largest single-substitution volume losses possible in protein chemistry. The π-stacking interaction with PHE825 is eliminated, the hydrophobic contact to MET781 is broken, and the resulting cavity is too large to be filled by side-chain repacking. The introduced hydroxyl group is polar and small, and would prefer to point toward solvent rather than into the hydrophobic pocket — further destabilizing the local fold.

DynaMut2 returns |ΔΔG| = 2.49 kcal/mol, placing W700S in Category 2 — moderately destabilizing but not gross-misfolding. The fold survives but is energetically compromised in proportion to the lost hydrophobic packing. Note that the W700C variant at the same position (Atlas card adjacent) shows |ΔΔG| of only -0.10 kcal/mol — replacing the indole with a thiol preserves more volume than replacing it with a hydroxyl, even though both are small polar groups. This W → C vs W → S contrast is a clean local example of how packing density, not just chemical class, drives WFS1 destabilization.

Amino-acid chemistry
Tryptophan (W) → Serine (S) — the bulkiest aromatic side chain in the genetic code replaced by a small polar hydroxyl. The volume difference is dramatic.
Position in the protein
C-terminal lumenal domain · position 700 lies inside the ER lumen, in a high-confidence region of the AlphaFold model (pLDDT 90).

Druggability Assessment

Category 2 — Moderately Destabilizing. |ΔΔG| = 2.49 kcal/mol places W700S just inside the moderately destabilizing range. The fold survives but a fraction of translated protein will be cleared by ER quality control before reaching its functional location.

This is a pharmacological chaperone candidate. The lost stability comes from a volume mismatch in a packed hydrophobic pocket — not from a broken specific bond or a disrupted catalytic site. The right intervention is a small molecule that stabilizes the wolframin fold globally, shifting the folding equilibrium toward functional protein. The CFTR-corrector analogy applies: rescue the folding yield, not the function.

Worth noting alongside the W700C card: W700 itself sits in a position where multiple pathogenic substitutions are documented, with substitution chemistry directly controlling severity. This makes W700 a useful didactic example of why structural context matters more than the position label alone — the variant cards must always be read at the specific substitution level.

Why this matters

W700S is one of two variants out of 245 in the Atlas where |ΔΔG| exceeds 2 kcal/mol. Both outliers stop well short of the 4 kcal/mol gross-misfolding threshold. The Atlas-wide finding holds: WFS1 pathogenic variants do not require gene therapy. They damage the fold in measurable but tractable ways. W700S adds nuance to that picture — even within a single position, the substitution chemistry determines whether the variant is mildly perturbing (W700C, |ΔΔG| 0.1) or moderately destabilizing (W700S, |ΔΔG| 2.5). The Atlas captures that resolution.
Therapeutic Strategy Handoff · prediction

Feed this card to Wolfram Intelligence

Download the W700S PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.

Download W700S PDF card ↓Strategies are AI-generated predictions, not validated therapeutics.

UniProt Domain Annotation

Chain1890 · Wolframin
Topological domain653869 · Lumenal
Natural variant700700 · in WFS1